Suppr超能文献

全谷物的肠道抗炎生物活性:一项针对有前驱糖尿病成年人的随机、对照、交叉膳食试验的原理、设计和方法。

Intestinal-level anti-inflammatory bioactivities of whole wheat: Rationale, design, and methods of a randomized, controlled, crossover dietary trial in adults with prediabetes.

机构信息

Human Nutrition Program, The Ohio State University, Columbus, OH, USA.

Human Nutrition Program, The Ohio State University, Columbus, OH, USA; James Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.

出版信息

Nutr Res. 2024 Nov;131:83-95. doi: 10.1016/j.nutres.2024.09.010. Epub 2024 Sep 18.

Abstract

Randomized controlled trials (RCT) demonstrate that whole wheat consumption improves glycemia. However, substantial inter-individual variation is often observed, highlighting that dietary whole grain recommendations may not support the health of all persons. The objective of this report is to describe the rationale and design of a planned RCT aimed at establishing the gut microbiota and metabolome signatures that predict whole wheat-mediated improvements in glucose tolerance in adults with prediabetes. It is hypothesized that a controlled diet containing wheat bread (WHEAT; 160 g/day) compared with refined bread (WHITE) will improve glucose tolerance in a gut microbiota-mediated manner. Biospecimens will be collected before and after each 2-week study arm. Testing for oral glucose tolerance and gastrointestinal permeability will be performed post-intervention. Assessments will include oral glucose tolerance (primary outcome) and secondary outcomes including gut microbiota, targeted and untargeted metabolomics of fecal and plasma samples, intestinal and host inflammatory responses, and intestinal permeability. WHEAT is predicted to alleviate glucose intolerance by shifting microbiota composition to increase short-chain fatty acid-producing bacteria while reducing populations implicated in intestinal inflammation, barrier dysfunction, and systemic endotoxemia. Further, benefits from WHEAT are anticipated to correlate with gut-level and systemic metabolomic responses that can help to explain the expected inter-individual variability in glucose tolerance. Thus, knowledge gained from integrating multi-omic responses associating with glucose tolerance could help to establish a precision nutrition-based framework that can alleviate cardiometabolic risk. This framework could inform novel dietary whole grain recommendations by enhancing our understanding of inter-individual responsiveness to whole grain consumption.

摘要

随机对照试验(RCT)表明,全麦食品的摄入可改善血糖水平。然而,个体间存在很大差异,这表明膳食纤维的摄入建议可能无法满足所有人的健康需求。本报告的目的是描述一项计划中的 RCT 的基本原理和设计,该 RCT 旨在确定肠道微生物组和代谢组特征,以预测全麦食品改善糖尿病前期成年人葡萄糖耐量的效果。研究假设,与精制面包(WHITE)相比,含小麦面包(WHEAT;160g/天)的对照饮食将以肠道微生物组介导的方式改善葡萄糖耐量。在每个为期 2 周的研究阶段前后将采集生物样本。干预后将进行口服葡萄糖耐量和胃肠道通透性测试。评估将包括口服葡萄糖耐量(主要终点)和次要终点,包括粪便和血浆样本的肠道微生物组、靶向和非靶向代谢组学、肠道和宿主炎症反应以及肠道通透性。预计 WHEAT 通过改变微生物组成,增加产生短链脂肪酸的细菌数量,同时减少与肠道炎症、屏障功能障碍和全身内毒素血症有关的菌群,从而缓解葡萄糖耐量异常。此外,预计 WHEAT 的益处将与肠道和全身代谢组学反应相关,这有助于解释葡萄糖耐量的个体间差异。因此,整合与葡萄糖耐量相关的多组学反应的知识可以帮助建立基于精准营养的框架,从而减轻心血管代谢风险。该框架可以通过增强对全谷物摄入的个体反应性的理解,为新型膳食纤维摄入建议提供信息。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验